Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin.

Rheumatology international - 1 Jan 2000

Cooper T, Savige J, Nassis L, Paspaliaris B, Neeson P, Neil J, Knight K R, Daskalakis M, Doery J C

Abstract excerpt

Bactericidal/permeability-increasing protein (BPI) and azurocidin (AZ) are recently described target antigens of antineutrophil cytoplasmic antibodies (ANCA). In this study, BPI-ANCA were demonstrated most often in patients with ulcerative colitis (36/92, 39%), Crohn's disease (17/66, 26%) and cystic fibrosis (11/14, 79%), but also in patients with rheumatoid arthritis (8/40, 20%), systemic lupus erythematosus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin
Share to Antibodies, Antineutrophil Cytoplasmic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antimicrobial Cationic Peptides

Share to Autoantibodies

Share to Autoimmune Diseases

Share to Blood Proteins

Share to Fluorescent Antibody Technique

Share to Immunoglobulins

Source

Identifiers

PMID: 10836522
DOI: 10.1007/s002960050116

Genes

BPI

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin.PMID 10836522Read ↗

New insights into clinical spectrum of antineutrophil cytoplasmic autoantibody associated disease.Semantic proximity Read ↗

Alpha1-antitrypsin phenotypes and anti-neutrophil cytoplasmic auto-antibodies in inflammatory bowel disease.Semantic proximity Read ↗

ANCA DiseaseSemantic proximity Read ↗

Antineutrophil cytoplasmic antibodies – their role in pathogenesis, diagnosis and treatment monitoring of ANCA-associated vasculitisSemantic proximity Read ↗

The prevalence and clinical significance of alpha 1-antitrypsin deficiency (PiZ) and ANCA specificities (proteinase 3, BPI) in patients with ulcerative colitis.Semantic proximity Read ↗

Alpha 1-antitrypsin activity is markedly decreased in Wegener's granulomatosis.Semantic proximity Read ↗

Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis.Semantic proximity Read ↗

Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects.Semantic proximity Read ↗

C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele.Semantic proximity Read ↗

Atypical perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease.Semantic proximity Read ↗

Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis.Semantic proximity Read ↗

Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.